My name is Bryan Doreian.
Bryan Doreian, PhD, is currently the President of Wyserbridge Patent Bar Review. Bryan is responsible for the operations, oversight, and management of all projects at Wysebridge. Bryan has spent years in bio- and medical- research, sharpening his knack for data analysis and analytical abilities while obtaining a PhD in Biophysics.
Bryan Doreian's Background
Bryan Doreian's Experience
President at The Wysebridge Company, LLC
Created and founded the Wysebridge Company during the process of studying for the Patent Bar Exam in 2012.
Wysebridge is a unique, online company offering dynamic and encompassing resources to individuals studying for the Patent Bar Exam. The company utilizes web based study materials in the form of content summaries, customizable testing resources, immediate personal support and feedback, and providing online forums to foster peer-peer discussions.
Executive Assistant to the President at The TriniCore Company
Directly responsible to the president of the TriniCore Company.
Improves quality results by studying, evaluating, and re-designing processes; implementing changes.
Provides information to callers and external sources, which requires a comprehensive knowledge of company policies, procedures and operations.
Post Doctoral Research Fellow at Case Western Reserve University, Department of Dermatology
July 2009 - December 2011 | Cleveland
Investigations of a hyper-inflammatory phenotype of macrophages generated through activation of PPAR-gamma receptors.
Studied delayed and chronic wound healing conditions, formulating the development of new anti-inflammatories and therapies.
Diverse background in the development of animal models of human diseases including chronic epidermal/dermal wounds and lung inflammation, small animal surgery, tissue culturing, and multi-variant experiment design.
Research Engineer, Product Development at Svenska Cellulosa Aktiebolaget SCA
May 2003 - March 2005
Responsible for improving quality control of polystyrene product import/export, as well as individual expanded polystyrene foam building forms (ICF's) production.
Established and implemented a novel production protocol optimizing production efficacy of ICF's.
Created a standardized training and product testing protocol for employees.
Drug Discovery Intern at Elan Pharmaceuticals
May 2000 - May 2003
Developed a novel assay to quantitatively analyze and optimize suspension of small (
Research Intern at NanoSystems LLC
May 1998 - May 2000
Responsible for acquisition and maintenance of the chemical inventory. Experience included acquisition of protocols, MSDS's, documentation of acquisition records, daily inspection of laboratory equipment. Conducted preliminary and investigatory experiments on drug suspensions.
Bryan Doreian's Education
Case Western Reserve University
2005 – 2009
Doctor of Philosophy (PhD)
2001 – 2005
Bachelor of Science (BS)
Concentration: Chemistry, Chemical Engineering
Bryan Doreian's Interests & Activities
Marketing, Bio-Medical Research, Science, Running, Writing Music, Cooking, Rock-Climbing, Art and Design,